ArticleCell reports. Medicine2021

The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota.

Stephen J Blake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.